Eli Lilly and Company
RNAi drug discovery expert responsible for evaluating scientific and business opportunities, designing and executing RNAi therapeutics, and partnering with Lilly Genetic Medicines LGM to ensure strategic alignment and maximum impact.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
85% above the average for this role
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Vice President, Preclinical & Translational Development
Tangram Interiors
Senior Director, RNAi Discovery
Pliant Therapeutics, Inc.
Associate Scientist - Biology
Amgen
Scientist to Principal Scientist, in-vitro Biology
Structure Therapeutics
Medicinal Chemist, Drug Discovery
Brigham and Women's Hospital
Senior Medicinal Chemist, Drug Discovery
SandboxAQ